nodes	percent_of_prediction	percent_of_DWPC	metapath
Nizatidine—BCHE—Triamcinolone—ankylosing spondylitis	0.43	0.455	CbGbCtD
Nizatidine—ABCB1—Methylprednisolone—ankylosing spondylitis	0.144	0.152	CbGbCtD
Nizatidine—ABCB1—Betamethasone—ankylosing spondylitis	0.0937	0.099	CbGbCtD
Nizatidine—ABCB1—Prednisolone—ankylosing spondylitis	0.0924	0.0977	CbGbCtD
Nizatidine—ABCB1—Prednisone—ankylosing spondylitis	0.0873	0.0923	CbGbCtD
Nizatidine—ABCB1—Dexamethasone—ankylosing spondylitis	0.0545	0.0576	CbGbCtD
Nizatidine—ABCB1—Methotrexate—ankylosing spondylitis	0.0438	0.0463	CbGbCtD
Nizatidine—Tooth disorder—Triamcinolone—ankylosing spondylitis	0.00128	0.0237	CcSEcCtD
Nizatidine—Vasculitis—Prednisolone—ankylosing spondylitis	0.000922	0.0171	CcSEcCtD
Nizatidine—Vasculitis—Triamcinolone—ankylosing spondylitis	0.000848	0.0158	CcSEcCtD
Nizatidine—Vasculitis—Methylprednisolone—ankylosing spondylitis	0.000846	0.0157	CcSEcCtD
Nizatidine—Vasculitis—Dexamethasone—ankylosing spondylitis	0.00077	0.0143	CcSEcCtD
Nizatidine—Vasculitis—Betamethasone—ankylosing spondylitis	0.00077	0.0143	CcSEcCtD
Nizatidine—Vasculitis—Prednisone—ankylosing spondylitis	0.00067	0.0125	CcSEcCtD
Nizatidine—Hyperuricaemia—Methotrexate—ankylosing spondylitis	0.000589	0.011	CcSEcCtD
Nizatidine—Hepatic enzyme increased—Methotrexate—ankylosing spondylitis	0.000578	0.0107	CcSEcCtD
Nizatidine—Irritability—Methylprednisolone—ankylosing spondylitis	0.000572	0.0106	CcSEcCtD
Nizatidine—Vasculitis—Methotrexate—ankylosing spondylitis	0.00056	0.0104	CcSEcCtD
Nizatidine—Blood uric acid increased—Methotrexate—ankylosing spondylitis	0.000557	0.0103	CcSEcCtD
Nizatidine—Irritability—Dexamethasone—ankylosing spondylitis	0.00052	0.00967	CcSEcCtD
Nizatidine—Irritability—Betamethasone—ankylosing spondylitis	0.00052	0.00967	CcSEcCtD
Nizatidine—Bronchospasm—Methylprednisolone—ankylosing spondylitis	0.00051	0.00948	CcSEcCtD
Nizatidine—Gynaecomastia—Methotrexate—ankylosing spondylitis	0.000489	0.00909	CcSEcCtD
Nizatidine—Irritability—Prednisone—ankylosing spondylitis	0.000453	0.00843	CcSEcCtD
Nizatidine—Sweating—Methylprednisolone—ankylosing spondylitis	0.000443	0.00823	CcSEcCtD
Nizatidine—Dermatitis exfoliative—Methotrexate—ankylosing spondylitis	0.000421	0.00782	CcSEcCtD
Nizatidine—Rhinitis—Triamcinolone—ankylosing spondylitis	0.000417	0.00775	CcSEcCtD
Nizatidine—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.000416	0.00773	CcSEcCtD
Nizatidine—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.000413	0.00767	CcSEcCtD
Nizatidine—Irritability—Methotrexate—ankylosing spondylitis	0.000379	0.00704	CcSEcCtD
Nizatidine—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.000378	0.00703	CcSEcCtD
Nizatidine—Back pain—Triamcinolone—ankylosing spondylitis	0.00035	0.00651	CcSEcCtD
Nizatidine—Convulsion—Prednisolone—ankylosing spondylitis	0.000341	0.00634	CcSEcCtD
Nizatidine—Eosinophilia—Methotrexate—ankylosing spondylitis	0.00034	0.00631	CcSEcCtD
Nizatidine—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000321	0.00597	CcSEcCtD
Nizatidine—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.000316	0.00587	CcSEcCtD
Nizatidine—Cough—Triamcinolone—ankylosing spondylitis	0.000316	0.00587	CcSEcCtD
Nizatidine—Convulsion—Triamcinolone—ankylosing spondylitis	0.000314	0.00583	CcSEcCtD
Nizatidine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000313	0.00582	CcSEcCtD
Nizatidine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000311	0.00577	CcSEcCtD
Nizatidine—Myalgia—Triamcinolone—ankylosing spondylitis	0.000308	0.00573	CcSEcCtD
Nizatidine—Pneumonia—Methotrexate—ankylosing spondylitis	0.000308	0.00572	CcSEcCtD
Nizatidine—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000307	0.00571	CcSEcCtD
Nizatidine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000306	0.0057	CcSEcCtD
Nizatidine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000301	0.0056	CcSEcCtD
Nizatidine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000297	0.00552	CcSEcCtD
Nizatidine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000295	0.00549	CcSEcCtD
Nizatidine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000295	0.00548	CcSEcCtD
Nizatidine—Infection—Triamcinolone—ankylosing spondylitis	0.000293	0.00545	CcSEcCtD
Nizatidine—Sweating—Methotrexate—ankylosing spondylitis	0.000293	0.00545	CcSEcCtD
Nizatidine—Infection—Methylprednisolone—ankylosing spondylitis	0.000293	0.00544	CcSEcCtD
Nizatidine—Insomnia—Prednisolone—ankylosing spondylitis	0.000291	0.0054	CcSEcCtD
Nizatidine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000286	0.00531	CcSEcCtD
Nizatidine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000285	0.0053	CcSEcCtD
Nizatidine—Convulsion—Betamethasone—ankylosing spondylitis	0.000285	0.00529	CcSEcCtD
Nizatidine—Convulsion—Dexamethasone—ankylosing spondylitis	0.000285	0.00529	CcSEcCtD
Nizatidine—Myalgia—Dexamethasone—ankylosing spondylitis	0.00028	0.0052	CcSEcCtD
Nizatidine—Myalgia—Betamethasone—ankylosing spondylitis	0.00028	0.0052	CcSEcCtD
Nizatidine—Anxiety—Dexamethasone—ankylosing spondylitis	0.000279	0.00518	CcSEcCtD
Nizatidine—Anxiety—Betamethasone—ankylosing spondylitis	0.000279	0.00518	CcSEcCtD
Nizatidine—Pain—Prednisolone—ankylosing spondylitis	0.000275	0.00511	CcSEcCtD
Nizatidine—Hepatitis—Methotrexate—ankylosing spondylitis	0.000275	0.0051	CcSEcCtD
Nizatidine—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000273	0.00507	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000269	0.005	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000269	0.00499	CcSEcCtD
Nizatidine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000268	0.00498	CcSEcCtD
Nizatidine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000268	0.00498	CcSEcCtD
Nizatidine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000267	0.00497	CcSEcCtD
Nizatidine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000267	0.00496	CcSEcCtD
Nizatidine—Infection—Betamethasone—ankylosing spondylitis	0.000266	0.00495	CcSEcCtD
Nizatidine—Infection—Dexamethasone—ankylosing spondylitis	0.000266	0.00495	CcSEcCtD
Nizatidine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000265	0.00492	CcSEcCtD
Nizatidine—Anaemia—Prednisone—ankylosing spondylitis	0.000264	0.00491	CcSEcCtD
Nizatidine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000262	0.00488	CcSEcCtD
Nizatidine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000262	0.00488	CcSEcCtD
Nizatidine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00026	0.00483	CcSEcCtD
Nizatidine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000259	0.00482	CcSEcCtD
Nizatidine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000259	0.00482	CcSEcCtD
Nizatidine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000259	0.00482	CcSEcCtD
Nizatidine—Anorexia—Dexamethasone—ankylosing spondylitis	0.000255	0.00475	CcSEcCtD
Nizatidine—Anorexia—Betamethasone—ankylosing spondylitis	0.000255	0.00475	CcSEcCtD
Nizatidine—Urticaria—Prednisolone—ankylosing spondylitis	0.000255	0.00474	CcSEcCtD
Nizatidine—Pain—Triamcinolone—ankylosing spondylitis	0.000253	0.0047	CcSEcCtD
Nizatidine—Convulsion—Prednisone—ankylosing spondylitis	0.000248	0.00461	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000244	0.00454	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000244	0.00454	CcSEcCtD
Nizatidine—Myalgia—Prednisone—ankylosing spondylitis	0.000243	0.00453	CcSEcCtD
Nizatidine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000243	0.00452	CcSEcCtD
Nizatidine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000243	0.00451	CcSEcCtD
Nizatidine—Anxiety—Prednisone—ankylosing spondylitis	0.000243	0.00451	CcSEcCtD
Nizatidine—Insomnia—Betamethasone—ankylosing spondylitis	0.000242	0.00451	CcSEcCtD
Nizatidine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000242	0.00451	CcSEcCtD
Nizatidine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000241	0.00448	CcSEcCtD
Nizatidine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000236	0.00439	CcSEcCtD
Nizatidine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000236	0.00439	CcSEcCtD
Nizatidine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000235	0.00436	CcSEcCtD
Nizatidine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000234	0.00435	CcSEcCtD
Nizatidine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000234	0.00434	CcSEcCtD
Nizatidine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000233	0.00434	CcSEcCtD
Nizatidine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000233	0.00433	CcSEcCtD
Nizatidine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000233	0.00433	CcSEcCtD
Nizatidine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000233	0.00433	CcSEcCtD
Nizatidine—Infection—Prednisone—ankylosing spondylitis	0.000232	0.00431	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000231	0.0043	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000231	0.0043	CcSEcCtD
Nizatidine—Back pain—Methotrexate—ankylosing spondylitis	0.000231	0.0043	CcSEcCtD
Nizatidine—Pain—Dexamethasone—ankylosing spondylitis	0.000229	0.00426	CcSEcCtD
Nizatidine—Pain—Betamethasone—ankylosing spondylitis	0.000229	0.00426	CcSEcCtD
Nizatidine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000226	0.00419	CcSEcCtD
Nizatidine—Anorexia—Prednisone—ankylosing spondylitis	0.000222	0.00414	CcSEcCtD
Nizatidine—Anaemia—Methotrexate—ankylosing spondylitis	0.000221	0.00411	CcSEcCtD
Nizatidine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000221	0.00411	CcSEcCtD
Nizatidine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000221	0.00411	CcSEcCtD
Nizatidine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000219	0.00407	CcSEcCtD
Nizatidine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000219	0.00407	CcSEcCtD
Nizatidine—Urticaria—Betamethasone—ankylosing spondylitis	0.000213	0.00396	CcSEcCtD
Nizatidine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000213	0.00396	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000213	0.00395	CcSEcCtD
Nizatidine—Dizziness—Prednisolone—ankylosing spondylitis	0.000212	0.00395	CcSEcCtD
Nizatidine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000212	0.00394	CcSEcCtD
Nizatidine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000212	0.00394	CcSEcCtD
Nizatidine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000212	0.00394	CcSEcCtD
Nizatidine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000212	0.00394	CcSEcCtD
Nizatidine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000212	0.00394	CcSEcCtD
Nizatidine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000211	0.00393	CcSEcCtD
Nizatidine—Insomnia—Prednisone—ankylosing spondylitis	0.000211	0.00392	CcSEcCtD
Nizatidine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000209	0.00388	CcSEcCtD
Nizatidine—Cough—Methotrexate—ankylosing spondylitis	0.000209	0.00388	CcSEcCtD
Nizatidine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000209	0.00388	CcSEcCtD
Nizatidine—Convulsion—Methotrexate—ankylosing spondylitis	0.000207	0.00385	CcSEcCtD
Nizatidine—Dyspepsia—Prednisone—ankylosing spondylitis	0.000205	0.00382	CcSEcCtD
Nizatidine—Chest pain—Methotrexate—ankylosing spondylitis	0.000203	0.00378	CcSEcCtD
Nizatidine—Myalgia—Methotrexate—ankylosing spondylitis	0.000203	0.00378	CcSEcCtD
Nizatidine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000203	0.00377	CcSEcCtD
Nizatidine—Rash—Prednisolone—ankylosing spondylitis	0.000203	0.00376	CcSEcCtD
Nizatidine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000202	0.00376	CcSEcCtD
Nizatidine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000202	0.00375	CcSEcCtD
Nizatidine—Headache—Prednisolone—ankylosing spondylitis	0.000201	0.00374	CcSEcCtD
Nizatidine—Constipation—Prednisone—ankylosing spondylitis	0.0002	0.00371	CcSEcCtD
Nizatidine—Confusional state—Methotrexate—ankylosing spondylitis	0.000197	0.00366	CcSEcCtD
Nizatidine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000195	0.00363	CcSEcCtD
Nizatidine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000195	0.00363	CcSEcCtD
Nizatidine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000195	0.00362	CcSEcCtD
Nizatidine—Infection—Methotrexate—ankylosing spondylitis	0.000194	0.0036	CcSEcCtD
Nizatidine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000192	0.00358	CcSEcCtD
Nizatidine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000192	0.00357	CcSEcCtD
Nizatidine—Asthenia—Betamethasone—ankylosing spondylitis	0.000192	0.00357	CcSEcCtD
Nizatidine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000191	0.00355	CcSEcCtD
Nizatidine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000191	0.00355	CcSEcCtD
Nizatidine—Nausea—Prednisolone—ankylosing spondylitis	0.000191	0.00355	CcSEcCtD
Nizatidine—Pruritus—Dexamethasone—ankylosing spondylitis	0.00019	0.00352	CcSEcCtD
Nizatidine—Pruritus—Betamethasone—ankylosing spondylitis	0.00019	0.00352	CcSEcCtD
Nizatidine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000189	0.00351	CcSEcCtD
Nizatidine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000188	0.00349	CcSEcCtD
Nizatidine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000187	0.00348	CcSEcCtD
Nizatidine—Rash—Triamcinolone—ankylosing spondylitis	0.000186	0.00346	CcSEcCtD
Nizatidine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000186	0.00346	CcSEcCtD
Nizatidine—Anorexia—Methotrexate—ankylosing spondylitis	0.000186	0.00346	CcSEcCtD
Nizatidine—Rash—Methylprednisolone—ankylosing spondylitis	0.000186	0.00345	CcSEcCtD
Nizatidine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000186	0.00345	CcSEcCtD
Nizatidine—Urticaria—Prednisone—ankylosing spondylitis	0.000185	0.00345	CcSEcCtD
Nizatidine—Headache—Triamcinolone—ankylosing spondylitis	0.000185	0.00344	CcSEcCtD
Nizatidine—Headache—Methylprednisolone—ankylosing spondylitis	0.000185	0.00343	CcSEcCtD
Nizatidine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000185	0.00343	CcSEcCtD
Nizatidine—Abdominal pain—Prednisone—ankylosing spondylitis	0.000185	0.00343	CcSEcCtD
Nizatidine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000183	0.00341	CcSEcCtD
Nizatidine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000183	0.00341	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000178	0.0033	CcSEcCtD
Nizatidine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000177	0.00329	CcSEcCtD
Nizatidine—Dizziness—Betamethasone—ankylosing spondylitis	0.000177	0.00329	CcSEcCtD
Nizatidine—Insomnia—Methotrexate—ankylosing spondylitis	0.000176	0.00328	CcSEcCtD
Nizatidine—Nausea—Triamcinolone—ankylosing spondylitis	0.000175	0.00326	CcSEcCtD
Nizatidine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000175	0.00325	CcSEcCtD
Nizatidine—Somnolence—Methotrexate—ankylosing spondylitis	0.000173	0.00322	CcSEcCtD
Nizatidine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000172	0.00319	CcSEcCtD
Nizatidine—Vomiting—Betamethasone—ankylosing spondylitis	0.00017	0.00317	CcSEcCtD
Nizatidine—Vomiting—Dexamethasone—ankylosing spondylitis	0.00017	0.00317	CcSEcCtD
Nizatidine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00017	0.00315	CcSEcCtD
Nizatidine—Rash—Betamethasone—ankylosing spondylitis	0.000169	0.00314	CcSEcCtD
Nizatidine—Rash—Dexamethasone—ankylosing spondylitis	0.000169	0.00314	CcSEcCtD
Nizatidine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000169	0.00314	CcSEcCtD
Nizatidine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000169	0.00314	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000168	0.00313	CcSEcCtD
Nizatidine—Headache—Dexamethasone—ankylosing spondylitis	0.000168	0.00312	CcSEcCtD
Nizatidine—Headache—Betamethasone—ankylosing spondylitis	0.000168	0.00312	CcSEcCtD
Nizatidine—Asthenia—Prednisone—ankylosing spondylitis	0.000167	0.00311	CcSEcCtD
Nizatidine—Pain—Methotrexate—ankylosing spondylitis	0.000167	0.0031	CcSEcCtD
Nizatidine—Pruritus—Prednisone—ankylosing spondylitis	0.000165	0.00307	CcSEcCtD
Nizatidine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000161	0.00299	CcSEcCtD
Nizatidine—Diarrhoea—Prednisone—ankylosing spondylitis	0.00016	0.00297	CcSEcCtD
Nizatidine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00016	0.00297	CcSEcCtD
Nizatidine—Nausea—Betamethasone—ankylosing spondylitis	0.000159	0.00296	CcSEcCtD
Nizatidine—Nausea—Dexamethasone—ankylosing spondylitis	0.000159	0.00296	CcSEcCtD
Nizatidine—Urticaria—Methotrexate—ankylosing spondylitis	0.000155	0.00288	CcSEcCtD
Nizatidine—Dizziness—Prednisone—ankylosing spondylitis	0.000154	0.00287	CcSEcCtD
Nizatidine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000154	0.00287	CcSEcCtD
Nizatidine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000154	0.00287	CcSEcCtD
Nizatidine—Vomiting—Prednisone—ankylosing spondylitis	0.000148	0.00276	CcSEcCtD
Nizatidine—Rash—Prednisone—ankylosing spondylitis	0.000147	0.00274	CcSEcCtD
Nizatidine—Dermatitis—Prednisone—ankylosing spondylitis	0.000147	0.00273	CcSEcCtD
Nizatidine—Headache—Prednisone—ankylosing spondylitis	0.000146	0.00272	CcSEcCtD
Nizatidine—Asthenia—Methotrexate—ankylosing spondylitis	0.00014	0.0026	CcSEcCtD
Nizatidine—Nausea—Prednisone—ankylosing spondylitis	0.000139	0.00258	CcSEcCtD
Nizatidine—Pruritus—Methotrexate—ankylosing spondylitis	0.000138	0.00257	CcSEcCtD
Nizatidine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000133	0.00248	CcSEcCtD
Nizatidine—Dizziness—Methotrexate—ankylosing spondylitis	0.000129	0.0024	CcSEcCtD
Nizatidine—Vomiting—Methotrexate—ankylosing spondylitis	0.000124	0.00231	CcSEcCtD
Nizatidine—Rash—Methotrexate—ankylosing spondylitis	0.000123	0.00229	CcSEcCtD
Nizatidine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000123	0.00228	CcSEcCtD
Nizatidine—Headache—Methotrexate—ankylosing spondylitis	0.000122	0.00227	CcSEcCtD
Nizatidine—Nausea—Methotrexate—ankylosing spondylitis	0.000116	0.00215	CcSEcCtD
